Navigation Links


Pharmaceuticals at Biology News

Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels

A team of scientists has discovered three molecules –?from a search of 58,000 compounds –?that appear to inhibit a key perpetrator of Alzheimer's disease. Ken Kosik, co...
Pharmaceuticals at Biology Products

CM Galactose Broth from Aestus Pharmaceuticals Corp.

Description:...
Company:

Water, USP Purified/WFI G from Aestus Pharmaceuticals Corp.

Description:US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
Company:Aestus Pharmaceuticals Corp.

CM Glucose Broth from Aestus Pharmaceuticals Corp.

Description:Growth Medium / Media...
Company:Aestus Pharmaceuticals Corp.
Pharmaceuticals at Biology Technology

Deltanoid Pharmaceuticals begins phase II osteoporosis study

The study is being conducted to determine whether 2MD can safely improve bone mineral density in postmenopausal women. Osteoporosis, a disease caused by the loss of nor...

The Coming of Biotech Generic Pharmaceuticals

CHICAGO In a column last year, I commented on the growing generic pharmaceuticals business in the U.S. and around the world. Generic pharmaceuticals are not only big business but will continue to get even bigger. There are a couple reasons why: The increased concern in the U.S. about rising drug pr...
Pharmaceuticals at Medicine News

Supply of Radiopharmaceuticals Hampered by Attacks

As a result of the September 11 terrorist acts in New York and Washington DC, air transportation in the United States was put on hold for several days, which severely affected the production and distribution of radiopharmaceuticals. Most radiopharmaceuticals are shipped via air due to their specific nature. These products are either radioactive themselves or they are pharmaceuticals wi...

FDA approves Watson Pharmaceuticals' Oxytrol patch

The Food and Drug Administration has approved a new patch developed by Watson Pharmaceuticals Inc., for the treatment of an overactive bladder. The patch called Oxytrol (generic: oxybutynin transdermal system) reduces urinary urge incontinence, urinary urgency, and urinary frequency, according to the drug's maker. Oral forms of oxybutynin has been around for around 25 years but it has not been po...

Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart

In a statement released by Ranbaxy Pharmaceuticals Inc (RPI), they have stated that have received the prestigious Supplier Award // from Wal-Mart, the largest chain store in the US, for outstanding performance in the first quarter of 2005. Wal-Mart Stores is a global company with more than 1.3 million associates worldwide and nearly 5,000 stores and wholesale clubs across 10 countries. <br...

Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine

Antigenics Pharmaceuticals is to start its Phase III cancer vaccine trial against Melanoma which is a type of skin cancer. Oncophage is the new skin cancer vaccine developed by Antigenics.// The vaccine trial of Oncophage which was conducted in 322 patients failed to meet the required statistically significance results compared to prolongation in survival and the vaccine was not shown to have any...

United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals

United Kingdom is lagging in innovation, as shown by the market share of new medicines in various countries, including primary care and hospital markets. Reports from various sources prove that Europe has shown very low growth in the field of pharmaceuticals and hospital care//. Europe has a new plan in order to counter the worsening competitive position of its biopharmaceutical enter...

More>>

Pharmaceuticals at Medicine Products
Pharmaceuticals at Medicine Technology

Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting

GENEVA, July 11, 2007 /PRNewswire/ -- InspirationBiopharmaceuticals today announced the presentation of preclinicaldata supporting the development of new, proprietary forms ofrecombinant Factor IX to treat patients with Hemophilia B. The datawere highlighted in an oral presentation and a poster session atthe XXIst Congress of the International Society on Thrombosis andHaemostasis (ISTH)...

BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Jul 11, 2007 - BioSantePharmaceuticals, Inc. (Amex: BPA) today announced new positiveresults demonstrating that its calcium phosphate (CaP)nanoparticle-based vaccine adjuvant, BioVant(TM), may serve as aneffective vaccine adjuvant for the development of a dose sparingvaccine against H5N1 avian flu, widely known as bird flu. The new results are based on...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- PortolaPharmaceuticals, Inc. announced positive Phase II data on its leadcompound, PRT054021, an oral Factor Xa inhibitor, today at the XXICongress of the International Society on Thrombosis and Haemostasis(ISTH) in Geneva, Switzerland. The EXPERT trial showed thatPRT054021 was safe, effective, and well tolerated for theprevention of venous th...

Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

- Results Fail to Demonstrate Meaningful Placebo Adjusted WeightLoss; Obesity Program to be Discontinued NEW YORK, July 09, 2007 /PRNewswire-FirstCall/ -- ManhattanPharmaceuticals, Inc. today announced results of the company's twoPhase 2a clinical trials of oral Oleoyl-estrone (OE). The resultsof both randomized, double-blind, placebo-controlled studies, onein common obesity and the other...

Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference

MALVERN, Pa., June 28, 2007 /PRNewswire-FirstCall/ -- AuxiliumPharmaceuticals, Inc. today announced that Mr. Armando Anido, ChiefExecutive Officer and President, and Mr. Jim Fickenscher, ChiefFinancial Officer, will participate in the 2007 CEUT EmergingGrowth Opportunities Conference to be held July 10 through July 12,2007 at the Mandarin Oriental Hotel in New York City. Mr. Anido issche...

More>>

Other TagsCholesterCholesterCholesterCholester
(Date:5/16/2008)...plc (LSE: HNT), "the Group",a leading internation...group headquartered in London, released its interi...rformance in the first quarter 2008 (the period,en...low., 15 May 2008, H...ement Statement, Record net new busine...
(Date:5/16/2008)... the lesson of helping others in t..., May 16 /PRNewswire/ -- In the aftermath of the,d...embers of China are,looking for ways to join in th...try, schools are running donation drives and fund-...Ms. Zhang Lijun, the 190-student strong,Nanjing Fu...
(Date:5/16/2008)...007, WASHINGTON, May 16 /PRNewswire-USNewswire/ -...ths, the National Cancer Institute (NCI) invested,...ncer research in 2007,according to updated statis... The two other federal agencies with significant c...trol and Prevention (CDC) and the,Department of De...
(Date:5/16/2008)...rce announced today the,hiring of John Mongeon as ...Mongeon formerly headed up the Government Services...ernment sales and marketing initiatives for,the CI...ions in the IT,industry., Mongeon, a resident of ... to spend more time with his two-year old son. In ...
Breaking Medicine News(10 mins):Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:Lung Cancer Still Lowest in Federal Funding 2
(Date:5/16/2008)...ssue of the Canadian Journal of Forest Research pr...nvolved in one of the first landscape-scale experi...derosa pine ecosystems. , The Blacks Mountain In... Service, Humboldt State University, Oregon State ...and Wildlife Conservation Society scientists colla...
(Date:5/16/2008)...concerns in maintaining germ-free homes for their ... the rapid adoption of anti-bacterial soaps and cl... antiseptic soaps now have come under scrutiny by ...an health concerns. , Two closely related anti... center of the debacle. Whereas triclosan (TCS) ha...
(Date:5/15/2008)...ontinued Growth in Biometrics Business in First Qu...-- BIO-key International,Inc. (OTC Bulletin Board...nger-based biometric identification solutions, tod...uarter ended March 31, 2008., 2008 First Quarter ...ng operations for the three months ended,March 31,...
(Date:5/15/2008)...an-caused global climate change has long been a co...nown public policy issue, the problem of excessive...own beyond a growing circle of environmental scien... environment and negatively alters local and globa..., Two new papers by leading environmental scienti...
Breaking Biology News(10 mins):Pioneering landscape-scale research releases first findings 2New study links fate of personal care products to environmental pollution and human health concerns 2New study links fate of personal care products to environmental pollution and human health concerns 3BIO-key(R) Reports First Quarter 2008 Results 2BIO-key(R) Reports First Quarter 2008 Results 3Addressing the 'nitrogen cascade' 2Addressing the 'nitrogen cascade' 3Consumer Reports Finds Filter Based Air Purifiers are Better Choice for Consumers 5573 1Consumer Reports Finds Filter Based Air Purifiers are Better Choice for Consumers 5573 2Consumer Reports Finds Filter Based Air Purifiers are Better Choice for Consumers 5573 3Consumer Reports Finds Filter Based Air Purifiers are Better Choice for Consumers 5573 4CDC Reports Prevalence of Worms Transmitted by Dogs and Cats to Humans is Higher Than Previously Understood 5571 1CDC Reports Prevalence of Worms Transmitted by Dogs and Cats to Humans is Higher Than Previously Understood 5571 2CDC Reports Prevalence of Worms Transmitted by Dogs and Cats to Humans is Higher Than Previously Understood 5571 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 1Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 1700 4Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 1Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 3Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 4Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 5
Other Contentscervicitischancrechancroid